BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ramezani A, Raj DS. The gut microbiome, kidney disease, and targeted interventions. J Am Soc Nephrol. 2014;25:657-670. [PMID: 24231662 DOI: 10.1681/asn.2013080905] [Cited by in Crossref: 353] [Cited by in F6Publishing: 201] [Article Influence: 39.2] [Reference Citation Analysis]
Number Citing Articles
1 Fogelman AM. TMAO is both a biomarker and a renal toxin. Circ Res 2015;116:396-7. [PMID: 25634968 DOI: 10.1161/CIRCRESAHA.114.305680] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
2 Graboski AL, Redinbo MR. Gut-Derived Protein-Bound Uremic Toxins. Toxins (Basel) 2020;12:E590. [PMID: 32932981 DOI: 10.3390/toxins12090590] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
3 Zhao X, Zhang Y, Guo R, Yu W, Zhang F, Wu F, Shang J. The Alteration in Composition and Function of Gut Microbiome in Patients with Type 2 Diabetes. J Diabetes Res 2020;2020:8842651. [PMID: 33224990 DOI: 10.1155/2020/8842651] [Reference Citation Analysis]
4 Zha Y, Qian Q. Protein Nutrition and Malnutrition in CKD and ESRD. Nutrients 2017;9:E208. [PMID: 28264439 DOI: 10.3390/nu9030208] [Cited by in Crossref: 72] [Cited by in F6Publishing: 51] [Article Influence: 14.4] [Reference Citation Analysis]
5 Dai H, Thomson AW, Rogers NM. Dendritic Cells as Sensors, Mediators, and Regulators of Ischemic Injury. Front Immunol 2019;10:2418. [PMID: 31681306 DOI: 10.3389/fimmu.2019.02418] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
6 Zeng YQ, Dai Z, Lu F, Lu Z, Liu X, Chen C, Qu P, Li D, Hua Z, Qu Y, Zou C. Emodin via colonic irrigation modulates gut microbiota and reduces uremic toxins in rats with chronic kidney disease. Oncotarget 2016;7:17468-78. [PMID: 27003359 DOI: 10.18632/oncotarget.8160] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 5.6] [Reference Citation Analysis]
7 Maraj M, Kuśnierz-Cabala B, Dumnicka P, Gala-Błądzińska A, Gawlik K, Pawlica-Gosiewska D, Ząbek-Adamska A, Mazur-Laskowska M, Ceranowicz P, Kuźniewski M. Malnutrition, Inflammation, Atherosclerosis Syndrome (MIA) and Diet Recommendations among End-Stage Renal Disease Patients Treated with Maintenance Hemodialysis. Nutrients 2018;10:E69. [PMID: 29324682 DOI: 10.3390/nu10010069] [Cited by in Crossref: 38] [Cited by in F6Publishing: 20] [Article Influence: 9.5] [Reference Citation Analysis]
8 Bungau SG, Behl T, Singh A, Sehgal A, Singh S, Chigurupati S, Vijayabalan S, Das S, Palanimuthu VR. Targeting Probiotics in Rheumatoid Arthritis. Nutrients 2021;13:3376. [PMID: 34684377 DOI: 10.3390/nu13103376] [Reference Citation Analysis]
9 Gryp T, Vanholder R, Vaneechoutte M, Glorieux G. p-Cresyl Sulfate. Toxins (Basel) 2017;9:E52. [PMID: 28146081 DOI: 10.3390/toxins9020052] [Cited by in Crossref: 136] [Cited by in F6Publishing: 117] [Article Influence: 27.2] [Reference Citation Analysis]
10 Lai S, Mazzaferro S, Muscaritoli M, Mastroluca D, Testorio M, Perrotta A, Esposito Y, Carta M, Campagna L, Di Grado M, Ramaccini C, De Leo S, Galani A, Amabile MI, Molfino A. Prebiotic Therapy with Inulin Associated with Low Protein Diet in Chronic Kidney Disease Patients: Evaluation of Nutritional, Cardiovascular and Psychocognitive Parameters. Toxins (Basel) 2020;12:E381. [PMID: 32526852 DOI: 10.3390/toxins12060381] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Zheng Y, Tang Z, You L, Wu Y, Liu J, Xue J. Trimethylamine-N-oxide is an independent risk factor for hospitalization events in patients receiving maintenance hemodialysis. Ren Fail 2020;42:580-6. [PMID: 32576072 DOI: 10.1080/0886022X.2020.1781170] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
12 Filipska I, Winiarska A, Knysak M, Stompór T. Contribution of Gut Microbiota-Derived Uremic Toxins to the Cardiovascular System Mineralization. Toxins (Basel) 2021;13:274. [PMID: 33920096 DOI: 10.3390/toxins13040274] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Mazidi M, Shekoohi N, Covic A, Mikhailidis DP, Banach M. Adverse Impact of Desulfovibrio spp. and Beneficial Role of Anaerostipes spp. on Renal Function: Insights from a Mendelian Randomization Analysis. Nutrients 2020;12:E2216. [PMID: 32722370 DOI: 10.3390/nu12082216] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
14 Ohkuma T, Iwase M, Fujii H, Ide H, Komorita Y, Yoshinari M, Oku Y, Higashi T, Oshiro A, Nakamura U, Kitazono T. Constipation and diabetic kidney disease: The Fukuoka Diabetes Registry. Clin Exp Nephrol 2021. [PMID: 34173920 DOI: 10.1007/s10157-021-02105-9] [Reference Citation Analysis]
15 Lee TH, Park D, Kim YJ, Lee I, Kim S, Oh CT, Kim JY, Yang J, Jo SK. Lactobacillus salivarius BP121 prevents cisplatin‑induced acute kidney injury by inhibition of uremic toxins such as indoxyl sulfate and p‑cresol sulfate via alleviating dysbiosis. Int J Mol Med 2020;45:1130-40. [PMID: 32124946 DOI: 10.3892/ijmm.2020.4495] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
16 Bryniarski MA, Hamarneh F, Yacoub R. The role of chronic kidney disease-associated dysbiosis in cardiovascular disease. Exp Biol Med (Maywood) 2019;244:514-25. [PMID: 30682892 DOI: 10.1177/1535370219826526] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
17 Fagundes RAB, Soder TF, Grokoski KC, Benetti F, Mendes RH. Probiotics in the treatment of chronic kidney disease: a systematic review. J Bras Nefrol 2018;40:278-86. [PMID: 29958304 DOI: 10.1590/2175-8239-jbn-3931] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
18 Koppe L, Fouque D, Soulage CO. The Role of Gut Microbiota and Diet on Uremic Retention Solutes Production in the Context of Chronic Kidney Disease. Toxins (Basel) 2018;10:E155. [PMID: 29652797 DOI: 10.3390/toxins10040155] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 6.5] [Reference Citation Analysis]
19 Raizada MK, Joe B, Bryan NS, Chang EB, Dewhirst FE, Borisy GG, Galis ZS, Henderson W, Jose PA, Ketchum CJ, Lampe JW, Pepine CJ, Pluznick JL, Raj D, Seals DR, Gioscia-Ryan RA, Tang WHW, Oh YS. Report of the National Heart, Lung, and Blood Institute Working Group on the Role of Microbiota in Blood Pressure Regulation: Current Status and Future Directions. Hypertension 2017:HYPERTENSIONAHA. [PMID: 28760940 DOI: 10.1161/HYPERTENSIONAHA.117.09699] [Cited by in Crossref: 28] [Cited by in F6Publishing: 17] [Article Influence: 5.6] [Reference Citation Analysis]
20 Rosas-Villegas A, Sánchez-Tapia M, Avila-Nava A, Ramírez V, Tovar AR, Torres N. Differential Effect of Sucrose and Fructose in Combination with a High Fat Diet on Intestinal Microbiota and Kidney Oxidative Stress. Nutrients 2017;9:E393. [PMID: 28420148 DOI: 10.3390/nu9040393] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 6.4] [Reference Citation Analysis]
21 Liu F, Li Z, Wang X, Xue C, Tang Q, Li RW. Microbial Co-Occurrence Patterns and Keystone Species in the Gut Microbial Community of Mice in Response to Stress and Chondroitin Sulfate Disaccharide. Int J Mol Sci 2019;20:E2130. [PMID: 31052157 DOI: 10.3390/ijms20092130] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
22 Rysz J, Franczyk B, Ławiński J, Olszewski R, Ciałkowska-Rysz A, Gluba-Brzózka A. The Impact of CKD on Uremic Toxins and Gut Microbiota. Toxins (Basel) 2021;13:252. [PMID: 33807343 DOI: 10.3390/toxins13040252] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
23 Cases A, Cigarrán-Guldrís S, Mas S, Gonzalez-Parra E. Vegetable-Based Diets for Chronic Kidney Disease? It Is Time to Reconsider. Nutrients 2019;11:E1263. [PMID: 31167346 DOI: 10.3390/nu11061263] [Cited by in Crossref: 37] [Cited by in F6Publishing: 28] [Article Influence: 12.3] [Reference Citation Analysis]
24 Verzola D, Bonanni A, Sofia A, Montecucco F, D'Amato E, Cademartori V, Parodi EL, Viazzi F, Venturelli C, Brunori G, Garibotto G. Toll-like receptor 4 signalling mediates inflammation in skeletal muscle of patients with chronic kidney disease. J Cachexia Sarcopenia Muscle 2017;8:131-44. [PMID: 27897392 DOI: 10.1002/jcsm.12129] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 6.3] [Reference Citation Analysis]
25 Panichi V, Rocchetti MT, Scatena A, Rosati A, Migliori M, Pizzarelli F, Gesualdo L; REDERT Study group. Long term variation of serum levels of uremic toxins in patients treated by post-dilution high volume on-line hemodiafiltration in comparison to standard low-flux bicarbonate dialysis: results from the REDERT study. J Nephrol 2017;30:583-91. [PMID: 28337716 DOI: 10.1007/s40620-017-0381-2] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 3.4] [Reference Citation Analysis]
26 Van Treuren W, Dodd D. Microbial Contribution to the Human Metabolome: Implications for Health and Disease. Annu Rev Pathol 2020;15:345-69. [PMID: 31622559 DOI: 10.1146/annurev-pathol-020117-043559] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 9.3] [Reference Citation Analysis]
27 Steenbeke M, Valkenburg S, Gryp T, Van Biesen W, Delanghe JR, Speeckaert MM, Glorieux G. Gut Microbiota and Their Derived Metabolites, a Search for Potential Targets to Limit Accumulation of Protein-Bound Uremic Toxins in Chronic Kidney Disease. Toxins (Basel) 2021;13:809. [PMID: 34822593 DOI: 10.3390/toxins13110809] [Reference Citation Analysis]
28 Kestenbaum B, Gamboa J, Liu S, Ali AS, Shankland E, Jue T, Giulivi C, Smith LR, Himmelfarb J, de Boer IH, Conley K, Roshanravan B. Impaired skeletal muscle mitochondrial bioenergetics and physical performance in chronic kidney disease. JCI Insight 2020;5:133289. [PMID: 32161192 DOI: 10.1172/jci.insight.133289] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 7.5] [Reference Citation Analysis]
29 Niska-Blakie J, Gopinathan L, Low KN, Kien YL, Goh CMF, Caldez MJ, Pfeiffenberger E, Jones OS, Ong CB, Kurochkin IV, Coppola V, Tessarollo L, Choi H, Kanagasundaram Y, Eisenhaber F, Maurer-Stroh S, Kaldis P. Knockout of the non-essential gene SUGCT creates diet-linked, age-related microbiome disbalance with a diabetes-like metabolic syndrome phenotype. Cell Mol Life Sci 2020;77:3423-39. [PMID: 31722069 DOI: 10.1007/s00018-019-03359-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
30 Chang CH, Kor CT, Wu CL, Chiu PF, Li JR, Tsai CC, Chang TH, Chang CC. Increased chronic kidney disease development and progression in diabetic patients after appendectomy: a population-based cohort study. PeerJ 2018;6:e5019. [PMID: 29915707 DOI: 10.7717/peerj.5019] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
31 Stubbs JR, Stedman MR, Liu S, Long J, Franchetti Y, West RE 3rd, Prokopienko AJ, Mahnken JD, Chertow GM, Nolin TD. Trimethylamine N-Oxide and Cardiovascular Outcomes in Patients with ESKD Receiving Maintenance Hemodialysis. Clin J Am Soc Nephrol 2019;14:261-7. [PMID: 30665924 DOI: 10.2215/CJN.06190518] [Cited by in Crossref: 26] [Cited by in F6Publishing: 14] [Article Influence: 8.7] [Reference Citation Analysis]
32 Barrows IR, Ramezani A, Raj DS. Gut Feeling in AKI: The Long Arm of Short-Chain Fatty Acids. J Am Soc Nephrol 2015;26:1755-7. [PMID: 25589611 DOI: 10.1681/ASN.2014111157] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
33 Jadoon A, Mathew AV, Byun J, Gadegbeku CA, Gipson DS, Afshinnia F, Pennathur S; for the Michigan Kidney Translational Core CPROBE Investigator Group. Gut Microbial Product Predicts Cardiovascular Risk in Chronic Kidney Disease Patients. Am J Nephrol 2018;48:269-77. [PMID: 30326477 DOI: 10.1159/000493862] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
34 Bindels LB, Delzenne NM, Cani PD, Walter J. Towards a more comprehensive concept for prebiotics. Nat Rev Gastroenterol Hepatol. 2015;12:303-310. [PMID: 25824997 DOI: 10.1038/nrgastro.2015.47] [Cited by in Crossref: 406] [Cited by in F6Publishing: 342] [Article Influence: 58.0] [Reference Citation Analysis]
35 Jia L, Dong X, Li X, Jia R, Zhang HL. Benefits of resistant starch type 2 for patients with end-stage renal disease under maintenance hemodialysis: a systematic review and meta-analysis. Int J Med Sci 2021;18:811-20. [PMID: 33437217 DOI: 10.7150/ijms.51484] [Reference Citation Analysis]
36 Missailidis C, Hällqvist J, Qureshi AR, Barany P, Heimbürger O, Lindholm B, Stenvinkel P, Bergman P. Serum Trimethylamine-N-Oxide Is Strongly Related to Renal Function and Predicts Outcome in Chronic Kidney Disease. PLoS One 2016;11:e0141738. [PMID: 26751065 DOI: 10.1371/journal.pone.0141738] [Cited by in Crossref: 142] [Cited by in F6Publishing: 139] [Article Influence: 23.7] [Reference Citation Analysis]
37 Sabatino A, D'Alessandro C, Regolisti G, di Mario F, Guglielmi G, Bazzocchi A, Fiaccadori E. Muscle mass assessment in renal disease: the role of imaging techniques. Quant Imaging Med Surg 2020;10:1672-86. [PMID: 32742960 DOI: 10.21037/qims.2020.03.05] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
38 Wang WL, Xu SY, Ren ZG, Tao L, Jiang JW, Zheng SS. Application of metagenomics in the human gut microbiome. World J Gastroenterol 2015; 21(3): 803-814 [PMID: 25624713 DOI: 10.3748/wjg.v21.i3.803] [Cited by in CrossRef: 174] [Cited by in F6Publishing: 127] [Article Influence: 24.9] [Reference Citation Analysis]
39 Sakkas H, Bozidis P, Touzios C, Kolios D, Athanasiou G, Athanasopoulou E, Gerou I, Gartzonika C. Nutritional Status and the Influence of the Vegan Diet on the Gut Microbiota and Human Health. Medicina (Kaunas) 2020;56:E88. [PMID: 32098430 DOI: 10.3390/medicina56020088] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
40 Riccio E, Sabbatini M, Bruzzese D, Grumetto L, Marchetiello C, Amicone M, Andreucci M, Guida B, Passaretti D, Russo G, Pisani A. Plasma p-cresol lowering effect of sevelamer in non-dialysis CKD patients: evidence from a randomized controlled trial. Clin Exp Nephrol 2018;22:529-38. [PMID: 29159529 DOI: 10.1007/s10157-017-1504-8] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
41 Yu S, Li C, Ji G, Zhang L. The Contribution of Dietary Fructose to Non-alcoholic Fatty Liver Disease. Front Pharmacol 2021;12:783393. [PMID: 34867414 DOI: 10.3389/fphar.2021.783393] [Reference Citation Analysis]
42 Banerjee T, Meyer TW, Shafi T, Hostetter TH, Melamed M, Zhu Y, Powe NR. Free and total p-cresol sulfate levels and infectious hospitalizations in hemodialysis patients in CHOICE and HEMO. Medicine (Baltimore) 2017;96:e5799. [PMID: 28178126 DOI: 10.1097/MD.0000000000005799] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
43 Asgari E, Garakani K, McHardy AC, Mofrad MRK. MicroPheno: predicting environments and host phenotypes from 16S rRNA gene sequencing using a k-mer based representation of shallow sub-samples. Bioinformatics 2018;34:i32-42. [PMID: 29950008 DOI: 10.1093/bioinformatics/bty296] [Cited by in Crossref: 28] [Cited by in F6Publishing: 20] [Article Influence: 9.3] [Reference Citation Analysis]
44 Rhee EP. A Systems-Level View of Renal Metabolomics. Semin Nephrol 2018;38:142-50. [PMID: 29602397 DOI: 10.1016/j.semnephrol.2018.01.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
45 Ahmadi Badi S, Tarashi S, Fateh A, Rohani P, Masotti A, Siadat SD. From the Role of Microbiota in Gut-Lung Axis to SARS-CoV-2 Pathogenesis. Mediators Inflamm 2021;2021:6611222. [PMID: 33953641 DOI: 10.1155/2021/6611222] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
46 Hung SC, Kuo KL, Wu CC, Tarng DC. Indoxyl Sulfate: A Novel Cardiovascular Risk Factor in Chronic Kidney Disease. J Am Heart Assoc 2017;6:e005022. [PMID: 28174171 DOI: 10.1161/JAHA.116.005022] [Cited by in Crossref: 73] [Cited by in F6Publishing: 44] [Article Influence: 14.6] [Reference Citation Analysis]
47 Barrios C, Beaumont M, Pallister T, Villar J, Goodrich JK, Clark A, Pascual J, Ley RE, Spector TD, Bell JT, Menni C. Gut-Microbiota-Metabolite Axis in Early Renal Function Decline.PLoS One. 2015;10:e0134311. [PMID: 26241311 DOI: 10.1371/journal.pone.0134311] [Cited by in Crossref: 72] [Cited by in F6Publishing: 66] [Article Influence: 10.3] [Reference Citation Analysis]
48 Vergano L, Loiacono E, Albera R, Coppo R, Camilla R, Peruzzi L, Amore A, Donadio ME, Chiale F, Boido A. Can tonsillectomy modify the innate and adaptive immunity pathways involved in IgA nephropathy? J Nephrol. 2015;28:51-58. [PMID: 24756968 DOI: 10.1007/s40620-014-0086-8] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
49 Zhao J, Zhang QL, Shen JH, Wang K, Liu J. Magnesium lithospermate B improves the gut microbiome and bile acid metabolic profiles in a mouse model of diabetic nephropathy. Acta Pharmacol Sin 2019;40:507-13. [PMID: 29941869 DOI: 10.1038/s41401-018-0029-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
50 Chaves LD, Abyad S, Honan AM, Bryniarski MA, McSkimming DI, Stahura CM, Wells SC, Ruszaj DM, Morris ME, Quigg RJ, Yacoub R. Unconjugated p-cresol activates macrophage macropinocytosis leading to increased LDL uptake. JCI Insight 2021;6:144410. [PMID: 33914709 DOI: 10.1172/jci.insight.144410] [Reference Citation Analysis]
51 Rychter AM, Ratajczak AE, Zawada A, Dobrowolska A, Krela-Kaźmierczak I. Non-Systematic Review of Diet and Nutritional Risk Factors of Cardiovascular Disease in Obesity. Nutrients 2020;12:E814. [PMID: 32204478 DOI: 10.3390/nu12030814] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
52 Szeto CC, McIntyre CW, Li PK. Circulating Bacterial Fragments as Cardiovascular Risk Factors in CKD. J Am Soc Nephrol 2018;29:1601-8. [PMID: 29666156 DOI: 10.1681/ASN.2018010068] [Cited by in Crossref: 16] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
53 Zawada A, Rychter AM, Ratajczak AE, Lisiecka-Masian A, Dobrowolska A, Krela-Kaźmierczak I. Does Gut-Microbiome Interaction Protect against Obesity and Obesity-Associated Metabolic Disorders? Microorganisms 2020;9:E18. [PMID: 33374597 DOI: 10.3390/microorganisms9010018] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
54 Chen W, Fitzpatrick J, Sozio SM, Jaar BG, Estrella MM, Riascos-Bernal DF, Wu TT, Qiu Y, Kurland IJ, Dubin RF, Chen Y, Parekh RS, Bushinsky DA, Sibinga NES. Identification of Novel Biomarkers and Pathways for Coronary Artery Calcification in Nondiabetic Patients on Hemodialysis Using Metabolomic Profiling. Kidney360 2021;2:279-89. [PMID: 34723191 DOI: 10.34067/kid.0004422020] [Reference Citation Analysis]
55 Maier JI, Rogg M, Helmstädter M, Sammarco A, Walz G, Werner M, Schell C. A Novel Model for Nephrotic Syndrome Reveals Associated Dysbiosis of the Gut Microbiome and Extramedullary Hematopoiesis. Cells 2021;10:1509. [PMID: 34203913 DOI: 10.3390/cells10061509] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
56 Wang W, Hao G, Pan Y, Ma S, Yang T, Shi P, Zhu Q, Xie Y, Ma S, Zhang Q, Ruan H, Ding F. Serum indoxyl sulfate is associated with mortality in hospital-acquired acute kidney injury: a prospective cohort study. BMC Nephrol 2019;20:57. [PMID: 30764800 DOI: 10.1186/s12882-019-1238-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
57 Li LZ, Tao SB, Ma L, Fu P. Roles of short-chain fatty acids in kidney diseases. Chin Med J (Engl) 2019;132:1228-32. [PMID: 30946066 DOI: 10.1097/CM9.0000000000000228] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
58 Szeto CC, Kwan BC, Chow KM, Kwok JS, Lai KB, Cheng PM, Pang WF, Ng JK, Chan MH, Lit LC, Leung CB, Li PK. Circulating bacterial-derived DNA fragment level is a strong predictor of cardiovascular disease in peritoneal dialysis patients. PLoS One 2015;10:e0125162. [PMID: 26010741 DOI: 10.1371/journal.pone.0125162] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.6] [Reference Citation Analysis]
59 Anupama PH, Prasad N, Nzana VB, Tiwari JP, Mathew M, Abraham G. Dietary Management in Slowing Down the Progression of CKDu. Indian J Nephrol 2020;30:256-60. [PMID: 33273790 DOI: 10.4103/ijn.IJN_366_18] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
60 Padmanabhan S, Joe B. Towards Precision Medicine for Hypertension: A Review of Genomic, Epigenomic, and Microbiomic Effects on Blood Pressure in Experimental Rat Models and Humans. Physiol Rev 2017;97:1469-528. [PMID: 28931564 DOI: 10.1152/physrev.00035.2016] [Cited by in Crossref: 52] [Cited by in F6Publishing: 47] [Article Influence: 10.4] [Reference Citation Analysis]
61 Al-Asmakh M, Sohail MU, Al-Jamal O, Shoair BM, Al-Baniali AY, Bouabidi S, Nasr S, Bawadi H. The Effects of Gum Acacia on the Composition of the Gut Microbiome and Plasma Levels of Short-Chain Fatty Acids in a Rat Model of Chronic Kidney Disease. Front Pharmacol 2020;11:569402. [PMID: 33628167 DOI: 10.3389/fphar.2020.569402] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
62 Nemati M, Omrani GR, Ebrahimi B, Montazeri-Najafabady N. The Beneficial Effects of Probiotics via Autophagy: A Systematic Review. Biomed Res Int 2021;2021:2931580. [PMID: 34901266 DOI: 10.1155/2021/2931580] [Reference Citation Analysis]
63 Almesned MA, Prins FM, Lipšic E, Connelly MA, Garcia E, Dullaart RPF, Groot HE, van der Harst P. Temporal Course of Plasma Trimethylamine N-Oxide (TMAO) Levels in ST-Elevation Myocardial Infarction. J Clin Med 2021;10:5677. [PMID: 34884379 DOI: 10.3390/jcm10235677] [Reference Citation Analysis]
64 Noce A, Marrone G, Ottaviani E, Guerriero C, Di Daniele F, Pietroboni Zaitseva A, Di Daniele N. Uremic Sarcopenia and Its Possible Nutritional Approach. Nutrients 2021;13:E147. [PMID: 33406683 DOI: 10.3390/nu13010147] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
65 Castaneda M, Strong JM, Alabi DA, Hernandez CJ. The Gut Microbiome and Bone Strength. Curr Osteoporos Rep 2020;18:677-83. [PMID: 33030683 DOI: 10.1007/s11914-020-00627-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
66 Contreras-Jodar A, Nayan NH, Hamzaoui S, Caja G, Salama AAK. Heat stress modifies the lactational performances and the urinary metabolomic profile related to gastrointestinal microbiota of dairy goats. PLoS One 2019;14:e0202457. [PMID: 30735497 DOI: 10.1371/journal.pone.0202457] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
67 Li Y, Dai M, Yan J, Liu F, Wang X, Lin L, Huang M, Li C, Wen R, Qin J, Xu H. Colonic dialysis can influence gut flora to protect renal function in patients with pre-dialysis chronic kidney disease. Sci Rep 2021;11:12773. [PMID: 34140540 DOI: 10.1038/s41598-021-91722-1] [Reference Citation Analysis]
68 Chan Q, Loo RL, Ebbels TM, Van Horn L, Daviglus ML, Stamler J, Nicholson JK, Holmes E, Elliott P. Metabolic phenotyping for discovery of urinary biomarkers of diet, xenobiotics and blood pressure in the INTERMAP Study: an overview. Hypertens Res 2017;40:336-45. [PMID: 28003647 DOI: 10.1038/hr.2016.164] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
69 Jovanovich A, Isakova T, Stubbs J. Microbiome and Cardiovascular Disease in CKD. Clin J Am Soc Nephrol 2018;13:1598-604. [PMID: 29743160 DOI: 10.2215/CJN.12691117] [Cited by in Crossref: 22] [Cited by in F6Publishing: 14] [Article Influence: 5.5] [Reference Citation Analysis]
70 Summers SC, Quimby JM, Isaiah A, Suchodolski JS, Lunghofer PJ, Gustafson DL. The fecal microbiome and serum concentrations of indoxyl sulfate and p-cresol sulfate in cats with chronic kidney disease. J Vet Intern Med 2019;33:662-9. [PMID: 30561098 DOI: 10.1111/jvim.15389] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 4.5] [Reference Citation Analysis]
71 Rivara MB, Zelnick LR, Hoofnagle AN, Newitt R, Tracy RP, Kratz M, Weigle DS, Kestenbaum BR. Diurnal and Long-term Variation in Plasma Concentrations and Renal Clearances of Circulating Markers of Kidney Proximal Tubular Secretion. Clin Chem 2017;63:915-23. [PMID: 28188231 DOI: 10.1373/clinchem.2016.260117] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
72 Stavropoulou E, Kantartzi K, Tsigalou C, Aftzoglou K, Voidarou C, Konstantinidis T, Chifiriuc MC, Thodis E, Bezirtzoglou E. Microbiome, Immunosenescence, and Chronic Kidney Disease. Front Med (Lausanne) 2021;8:661203. [PMID: 33816535 DOI: 10.3389/fmed.2021.661203] [Reference Citation Analysis]
73 Rafieian-Kopaei M, Beigrezaei S, Nasri H, Kafeshani M. Soy Protein and Chronic Kidney Disease: An Updated Review. Int J Prev Med 2017;8:105. [PMID: 29416834 DOI: 10.4103/ijpvm.IJPVM_244_17] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
74 Khosroshahi HT, Abedi B, Ghojazadeh M, Samadi A, Jouyban A. Effects of fermentable high fiber diet supplementation on gut derived and conventional nitrogenous product in patients on maintenance hemodialysis: a randomized controlled trial. Nutr Metab (Lond) 2019;16:18. [PMID: 30911321 DOI: 10.1186/s12986-019-0343-x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 7.3] [Reference Citation Analysis]
75 Rhee EP. Metabolomics and renal disease. Curr Opin Nephrol Hypertens 2015;24:371-9. [PMID: 26050125 DOI: 10.1097/MNH.0000000000000136] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
76 Vitetta L. Lactobacillus acidophilus Restores Functionality in Uremic Macrophages: Plausible or Lacking Evidence? Dig Dis Sci 2016;61:1417-9. [PMID: 26888768 DOI: 10.1007/s10620-016-4084-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
77 Gonzalez A, Krieg R, Massey HD, Carl D, Ghosh S, Gehr TWB, Ghosh SS. Sodium butyrate ameliorates insulin resistance and renal failure in CKD rats by modulating intestinal permeability and mucin expression. Nephrol Dial Transplant 2019;34:783-94. [PMID: 30085297 DOI: 10.1093/ndt/gfy238] [Cited by in Crossref: 31] [Cited by in F6Publishing: 34] [Article Influence: 15.5] [Reference Citation Analysis]
78 Tu P, Gao B, Chi L, Lai Y, Bian X, Ru H, Lu K. Subchronic low-dose 2,4-D exposure changed plasma acylcarnitine levels and induced gut microbiome perturbations in mice. Sci Rep 2019;9:4363. [PMID: 30867497 DOI: 10.1038/s41598-019-40776-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
79 Yu W, Shang J, Guo R, Zhang F, Zhang W, Zhang Y, Wu F, Ren H, Liu C, Xiao J, Zhao Z. The gut microbiome in differential diagnosis of diabetic kidney disease and membranous nephropathy. Ren Fail 2020;42:1100-10. [PMID: 33121301 DOI: 10.1080/0886022X.2020.1837869] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
80 Sumida K, Molnar MZ, Potukuchi PK, Thomas F, Lu JL, Yamagata K, Kalantar-Zadeh K, Kovesdy CP. Constipation and risk of death and cardiovascular events. Atherosclerosis 2019;281:114-20. [PMID: 30658186 DOI: 10.1016/j.atherosclerosis.2018.12.021] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 7.3] [Reference Citation Analysis]
81 Chen YY, Chen DQ, Chen L, Liu JR, Vaziri ND, Guo Y, Zhao YY. Microbiome-metabolome reveals the contribution of gut-kidney axis on kidney disease. J Transl Med 2019;17:5. [PMID: 30602367 DOI: 10.1186/s12967-018-1756-4] [Cited by in Crossref: 86] [Cited by in F6Publishing: 84] [Article Influence: 28.7] [Reference Citation Analysis]
82 Tang WH. Trimethylamine N-Oxide as a Novel Therapeutic Target in CKD. J Am Soc Nephrol 2016;27:8-10. [PMID: 26229138 DOI: 10.1681/ASN.2015050576] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
83 Prokopienko AJ, West RE 3rd, Stubbs JR, Nolin TD. Development and validation of a UHPLC-MS/MS method for measurement of a gut-derived uremic toxin panel in human serum: An application in patients with kidney disease. J Pharm Biomed Anal 2019;174:618-24. [PMID: 31276982 DOI: 10.1016/j.jpba.2019.06.033] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 3.3] [Reference Citation Analysis]
84 Sabatino A, Cuppari L, Stenvinkel P, Lindholm B, Avesani CM. Sarcopenia in chronic kidney disease: what have we learned so far? J Nephrol 2021;34:1347-72. [PMID: 32876940 DOI: 10.1007/s40620-020-00840-y] [Cited by in Crossref: 14] [Cited by in F6Publishing: 19] [Article Influence: 7.0] [Reference Citation Analysis]
85 Tang WH, Wang Z, Kennedy DJ, Wu Y, Buffa JA, Agatisa-Boyle B, Li XS, Levison BS, Hazen SL. Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease. Circ Res. 2015;116:448-455. [PMID: 25599331 DOI: 10.1161/circresaha.116.305360] [Cited by in Crossref: 530] [Cited by in F6Publishing: 310] [Article Influence: 66.3] [Reference Citation Analysis]
86 Rhee EP. How Omics Data Can Be Used in Nephrology. Am J Kidney Dis 2018;72:129-35. [PMID: 29478865 DOI: 10.1053/j.ajkd.2017.12.008] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
87 Wehedy E, Shatat IF, Al Khodor S. The Human Microbiome in Chronic Kidney Disease: A Double-Edged Sword. Front Med 2022;8:790783. [DOI: 10.3389/fmed.2021.790783] [Reference Citation Analysis]
88 Xu H, Huang X, Risérus U, Krishnamurthy VM, Cederholm T, Arnlöv J, Lindholm B, Sjögren P, Carrero JJ. Dietary fiber, kidney function, inflammation, and mortality risk. Clin J Am Soc Nephrol 2014;9:2104-10. [PMID: 25280496 DOI: 10.2215/CJN.02260314] [Cited by in Crossref: 47] [Cited by in F6Publishing: 13] [Article Influence: 5.9] [Reference Citation Analysis]
89 van den Brand JA, Mutsaers HA, van Zuilen AD, Blankestijn PJ, van den Broek PH, Russel FG, Masereeuw R, Wetzels JF. Uremic Solutes in Chronic Kidney Disease and Their Role in Progression. PLoS One 2016;11:e0168117. [PMID: 28033375 DOI: 10.1371/journal.pone.0168117] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
90 Noel S, Martina-Lingua MN, Bandapalle S, Pluznick J, Hamad AR, Peterson DA, Rabb H. Intestinal microbiota-kidney cross talk in acute kidney injury and chronic kidney disease. Nephron Clin Pract. 2014;127:139-143. [PMID: 25343838 DOI: 10.1159/000363209] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 3.5] [Reference Citation Analysis]
91 Grabowska-Polanowska B, Miarka P, Skowron M, Chmiel G, Pietrzycka A, Śliwka I. Breath analysis as promising indicator of hemodialysis efficiency. Clin Exp Nephrol 2019;23:251-7. [PMID: 30121801 DOI: 10.1007/s10157-018-1625-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
92 Andersen K, Kesper MS, Marschner JA, Konrad L, Ryu M, Kumar Vr S, Kulkarni OP, Mulay SR, Romoli S, Demleitner J, Schiller P, Dietrich A, Müller S, Gross O, Ruscheweyh HJ, Huson DH, Stecher B, Anders HJ. Intestinal Dysbiosis, Barrier Dysfunction, and Bacterial Translocation Account for CKD-Related Systemic Inflammation. J Am Soc Nephrol 2017;28:76-83. [PMID: 27151924 DOI: 10.1681/ASN.2015111285] [Cited by in Crossref: 95] [Cited by in F6Publishing: 60] [Article Influence: 15.8] [Reference Citation Analysis]
93 Suryavanshi MV, Bhute SS, Gune RP, Shouche YS. Functional eubacteria species along with trans-domain gut inhabitants favour dysgenic diversity in oxalate stone disease. Sci Rep 2018;8:16598. [PMID: 30413731 DOI: 10.1038/s41598-018-33773-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
94 Jose PA, Raj D. Gut microbiota in hypertension. Curr Opin Nephrol Hypertens 2015;24:403-9. [PMID: 26125644 DOI: 10.1097/MNH.0000000000000149] [Cited by in Crossref: 90] [Cited by in F6Publishing: 46] [Article Influence: 15.0] [Reference Citation Analysis]
95 Marzocco S, Fazeli G, Di Micco L, Autore G, Adesso S, Dal Piaz F, Heidland A, Di Iorio B. Supplementation of Short-Chain Fatty Acid, Sodium Propionate, in Patients on Maintenance Hemodialysis: Beneficial Effects on Inflammatory Parameters and Gut-Derived Uremic Toxins, A Pilot Study (PLAN Study). J Clin Med 2018;7:E315. [PMID: 30274359 DOI: 10.3390/jcm7100315] [Cited by in Crossref: 27] [Cited by in F6Publishing: 31] [Article Influence: 6.8] [Reference Citation Analysis]
96 Mafra D, Borges N, Alvarenga L, Esgalhado M, Cardozo L, Lindholm B, Stenvinkel P. Dietary Components That May Influence the Disturbed Gut Microbiota in Chronic Kidney Disease. Nutrients 2019;11:E496. [PMID: 30818761 DOI: 10.3390/nu11030496] [Cited by in Crossref: 47] [Cited by in F6Publishing: 34] [Article Influence: 15.7] [Reference Citation Analysis]
97 Koppe L, Mafra D, Fouque D. Probiotics and chronic kidney disease. Kidney Int. 2015;88:958-966. [PMID: 26376131 DOI: 10.1038/ki.2015.255] [Cited by in Crossref: 106] [Cited by in F6Publishing: 89] [Article Influence: 15.1] [Reference Citation Analysis]
98 Hobby GP, Karaduta O, Dusio GF, Singh M, Zybailov BL, Arthur JM. Chronic kidney disease and the gut microbiome. Am J Physiol Renal Physiol 2019;316:F1211-7. [PMID: 30864840 DOI: 10.1152/ajprenal.00298.2018] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 8.3] [Reference Citation Analysis]
99 Chrzastek K, Leng J, Zakaria MK, Bialy D, La Ragione R, Shelton H. Low pathogenic avian influenza virus infection retards colon microbiota diversification in two different chicken lines. Anim Microbiome 2021;3:64. [PMID: 34583770 DOI: 10.1186/s42523-021-00128-x] [Reference Citation Analysis]
100 Furuse SU, Ohse T, Jo-Watanabe A, Shigehisa A, Kawakami K, Matsuki T, Chonan O, Nangaku M. Galacto-oligosaccharides attenuate renal injury with microbiota modification. Physiol Rep 2014;2:e12029. [PMID: 24994892 DOI: 10.14814/phy2.12029] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 3.8] [Reference Citation Analysis]
101 Nlandu Y, Padden M, Seidowsky A, Hamaz S, Vilaine É, Cheddani L, Essig M, Massy ZA. Toxines urémiques de moyen poids moléculaire : un véritable regain d’intérêt. Néphrologie & Thérapeutique 2019;15:82-90. [DOI: 10.1016/j.nephro.2018.09.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
102 Souza AC, Tsuji T, Baranova IN, Bocharov AV, Wilkins KJ, Street JM, Alvarez-Prats A, Hu X, Eggerman T, Yuen PS, Star RA. TLR4 mutant mice are protected from renal fibrosis and chronic kidney disease progression. Physiol Rep 2015;3:e12558. [PMID: 26416975 DOI: 10.14814/phy2.12558] [Cited by in Crossref: 51] [Cited by in F6Publishing: 50] [Article Influence: 7.3] [Reference Citation Analysis]
103 Jones-Freeman B, Chonwerawong M, Marcelino VR, Deshpande AV, Forster SC, Starkey MR. The microbiome and host mucosal interactions in urinary tract diseases. Mucosal Immunol 2021;14:779-92. [PMID: 33542492 DOI: 10.1038/s41385-020-00372-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
104 Schijvens AM, de Wildt SN, Schreuder MF. Pharmacokinetics in children with chronic kidney disease. Pediatr Nephrol 2020;35:1153-72. [PMID: 31375913 DOI: 10.1007/s00467-019-04304-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
105 Noce A, Marrone G, Wilson Jones G, Di Lauro M, Pietroboni Zaitseva A, Ramadori L, Celotto R, Mitterhofer AP, Di Daniele N. Nutritional Approaches for the Management of Metabolic Acidosis in Chronic Kidney Disease. Nutrients 2021;13:2534. [PMID: 34444694 DOI: 10.3390/nu13082534] [Reference Citation Analysis]
106 Hsu CN, Chang-Chien GP, Lin S, Hou CY, Lu PC, Tain YL. Association of Trimethylamine, Trimethylamine N-oxide, and Dimethylamine with Cardiovascular Risk in Children with Chronic Kidney Disease. J Clin Med 2020;9:E336. [PMID: 31991725 DOI: 10.3390/jcm9020336] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
107 Alvarenga L, Cardozo LFMF, Lindholm B, Stenvinkel P, Mafra D. Intestinal alkaline phosphatase modulation by food components: predictive, preventive, and personalized strategies for novel treatment options in chronic kidney disease. EPMA J 2020;11:565-79. [PMID: 33240450 DOI: 10.1007/s13167-020-00228-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
108 Lai S, Molfino A, Testorio M, Perrotta AM, Currado A, Pintus G, Pietrucci D, Unida V, La Rocca D, Biocca S, Desideri A. Effect of Low-Protein Diet and Inulin on Microbiota and Clinical Parameters in Patients with Chronic Kidney Disease. Nutrients 2019;11:E3006. [PMID: 31818021 DOI: 10.3390/nu11123006] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
109 Ramezani A, Massy ZA, Meijers B, Evenepoel P, Vanholder R, Raj DS. Role of the Gut Microbiome in Uremia: A Potential Therapeutic Target. Am J Kidney Dis. 2016;67:483-498. [PMID: 26590448 DOI: 10.1053/j.ajkd.2015.09.027] [Cited by in Crossref: 153] [Cited by in F6Publishing: 139] [Article Influence: 21.9] [Reference Citation Analysis]
110 Andrade-Oliveira V, Amano MT, Correa-Costa M, Castoldi A, Felizardo RJ, de Almeida DC, Bassi EJ, Moraes-Vieira PM, Hiyane MI, Rodas AC, Peron JP, Aguiar CF, Reis MA, Ribeiro WR, Valduga CJ, Curi R, Vinolo MA, Ferreira CM, Câmara NO. Gut Bacteria Products Prevent AKI Induced by Ischemia-Reperfusion. J Am Soc Nephrol 2015;26:1877-88. [PMID: 25589612 DOI: 10.1681/ASN.2014030288] [Cited by in Crossref: 201] [Cited by in F6Publishing: 119] [Article Influence: 28.7] [Reference Citation Analysis]
111 Zhao Y, Cai Y, Cui LY, Tang W, Liu B, Zheng JJ, Si WZ, Wang X, Xu MJ. Suppression of Gut Bacterial Translocation Ameliorates Vascular Calcification through Inhibiting Toll-Like Receptor 9-Mediated BMP-2 Expression. Oxid Med Cell Longev 2019;2019:3415682. [PMID: 31007833 DOI: 10.1155/2019/3415682] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
112 Thongprayoon C, Kaewput W, Hatch ST, Bathini T, Sharma K, Wijarnpreecha K, Ungprasert P, D'Costa M, Mao MA, Cheungpasitporn W. Effects of Probiotics on Inflammation and Uremic Toxins Among Patients on Dialysis: A Systematic Review and Meta-Analysis. Dig Dis Sci 2019;64:469-79. [PMID: 30099652 DOI: 10.1007/s10620-018-5243-9] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
113 Chi M, Ma K, Wang J, Ding Z, Li Y, Zhu S, Liang X, Zhang Q, Song L, Liu C. The Immunomodulatory Effect of the Gut Microbiota in Kidney Disease. J Immunol Res 2021;2021:5516035. [PMID: 34095319 DOI: 10.1155/2021/5516035] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
114 Yaron JR, Ambadapadi S, Zhang L, Chavan RN, Tibbetts SA, Keinan S, Varsani A, Maldonado J, Kraberger S, Tafoya AM, Bullard WL, Kilbourne J, Stern-Harbutte A, Krajmalnik-Brown R, Munk BH, Koppang EO, Lim ES, Lucas AR. Immune protection is dependent on the gut microbiome in a lethal mouse gammaherpesviral infection. Sci Rep 2020;10:2371. [PMID: 32047224 DOI: 10.1038/s41598-020-59269-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
115 Kim JE, Kim HE, Park JI, Cho H, Kwak MJ, Kim BY, Yang SH, Lee JP, Kim DK, Joo KW, Kim YS, Kim BS, Lee H. The Association between Gut Microbiota and Uremia of Chronic Kidney Disease. Microorganisms 2020;8:E907. [PMID: 32560104 DOI: 10.3390/microorganisms8060907] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
116 Zhou H, Suo J, Zhu J. [Therapeutic Relevance of Human Microbiota and Lung Cancer]. Zhongguo Fei Ai Za Zhi 2019;22:464-9. [PMID: 31315786 DOI: 10.3779/j.issn.1009-3419.2019.07.09] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
117 Carracedo J, Alique M, Vida C, Bodega G, Ceprián N, Morales E, Praga M, de Sequera P, Ramírez R. Mechanisms of Cardiovascular Disorders in Patients With Chronic Kidney Disease: A Process Related to Accelerated Senescence. Front Cell Dev Biol 2020;8:185. [PMID: 32266265 DOI: 10.3389/fcell.2020.00185] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 7.5] [Reference Citation Analysis]
118 Pongking T, Haonon O, Dangtakot R, Onsurathum S, Jusakul A, Intuyod K, Sangka A, Anutrakulchai S, Cha'on U, Pinlaor S, Pinlaor P. A combination of monosodium glutamate and high-fat and high-fructose diets increases the risk of kidney injury, gut dysbiosis and host-microbial co-metabolism. PLoS One 2020;15:e0231237. [PMID: 32267892 DOI: 10.1371/journal.pone.0231237] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
119 Uy N, Graf L, Lemley KV, Kaskel F. Effects of gluten-free, dairy-free diet on childhood nephrotic syndrome and gut microbiota. Pediatr Res 2015;77:252-5. [PMID: 25310757 DOI: 10.1038/pr.2014.159] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
120 Bajaj JS, Thacker LR, Fagan A, White MB, Gavis EA, Hylemon PB, Brown R, Acharya C, Heuman DM, Fuchs M, Dalmet S, Sikaroodi M, Gillevet PM. Gut microbial RNA and DNA analysis predicts hospitalizations in cirrhosis. JCI Insight 2018;3:98019. [PMID: 29515036 DOI: 10.1172/jci.insight.98019] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 5.5] [Reference Citation Analysis]
121 Sumida K, Yamagata K, Kovesdy CP. Constipation in CKD. Kidney Int Rep 2020;5:121-34. [PMID: 32043026 DOI: 10.1016/j.ekir.2019.11.002] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 6.7] [Reference Citation Analysis]
122 Sirich TL, Plummer NS, Gardner CD, Hostetter TH, Meyer TW. Effect of increasing dietary fiber on plasma levels of colon-derived solutes in hemodialysis patients. Clin J Am Soc Nephrol 2014;9:1603-10. [PMID: 25147155 DOI: 10.2215/CJN.00490114] [Cited by in Crossref: 154] [Cited by in F6Publishing: 77] [Article Influence: 19.3] [Reference Citation Analysis]
123 Han N, Pan Z, Liu G, Yang R, Yujing B. Hypoxia: The "Invisible Pusher" of Gut Microbiota. Front Microbiol 2021;12:690600. [PMID: 34367091 DOI: 10.3389/fmicb.2021.690600] [Reference Citation Analysis]
124 Long W, Xue Z, Zhang Q, Feng Z, Bridgewater L, Wang L, Zhao L, Pang X. Differential responses of gut microbiota to the same prebiotic formula in oligotrophic and eutrophic batch fermentation systems. Sci Rep 2015;5:13469. [PMID: 26305380 DOI: 10.1038/srep13469] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
125 Stubbs JR, House JA, Ocque AJ, Zhang S, Johnson C, Kimber C, Schmidt K, Gupta A, Wetmore JB, Nolin TD, Spertus JA, Yu AS. Serum Trimethylamine-N-Oxide is Elevated in CKD and Correlates with Coronary Atherosclerosis Burden. J Am Soc Nephrol 2016;27:305-13. [PMID: 26229137 DOI: 10.1681/ASN.2014111063] [Cited by in Crossref: 194] [Cited by in F6Publishing: 126] [Article Influence: 27.7] [Reference Citation Analysis]
126 Davis SC, Yadav JS, Barrow SD, Robertson BK. Gut microbiome diversity influenced more by the Westernized dietary regime than the body mass index as assessed using effect size statistic. Microbiologyopen 2017;6. [PMID: 28677210 DOI: 10.1002/mbo3.476] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 4.6] [Reference Citation Analysis]
127 Gupta S, Sen U. More than just an enzyme: Dipeptidyl peptidase-4 (DPP-4) and its association with diabetic kidney remodelling. Pharmacol Res 2019;147:104391. [PMID: 31401210 DOI: 10.1016/j.phrs.2019.104391] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
128 Mertowska P, Mertowski S, Wojnicka J, Korona-Głowniak I, Grywalska E, Błażewicz A, Załuska W. A Link between Chronic Kidney Disease and Gut Microbiota in Immunological and Nutritional Aspects. Nutrients 2021;13:3637. [PMID: 34684638 DOI: 10.3390/nu13103637] [Reference Citation Analysis]
129 Winther SA, Henriksen P, Vogt JK, Hansen TH, Ahonen L, Suvitaival T, Hein Zobel E, Frimodt-Møller M, Hansen TW, Hansen T, Parving HH, Legido-Quigley C, Rossing P, Pedersen O. Gut microbiota profile and selected plasma metabolites in type 1 diabetes without and with stratification by albuminuria. Diabetologia 2020;63:2713-24. [PMID: 32886190 DOI: 10.1007/s00125-020-05260-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
130 Solak Y, Afsar B, Vaziri ND, Aslan G, Yalcin CE, Covic A, Kanbay M. Hypertension as an autoimmune and inflammatory disease. Hypertens Res 2016;39:567-73. [PMID: 27053010 DOI: 10.1038/hr.2016.35] [Cited by in Crossref: 90] [Cited by in F6Publishing: 83] [Article Influence: 15.0] [Reference Citation Analysis]
131 Kieffer DA, Piccolo BD, Vaziri ND, Liu S, Lau WL, Khazaeli M, Nazertehrani S, Moore ME, Marco ML, Martin RJ, Adams SH. Resistant starch alters gut microbiome and metabolomic profiles concurrent with amelioration of chronic kidney disease in rats. Am J Physiol Renal Physiol 2016;310:F857-71. [PMID: 26841824 DOI: 10.1152/ajprenal.00513.2015] [Cited by in Crossref: 117] [Cited by in F6Publishing: 116] [Article Influence: 19.5] [Reference Citation Analysis]
132 Pluznick JL. Gut microbiota in renal physiology: focus on short-chain fatty acids and their receptors. Kidney Int 2016;90:1191-8. [PMID: 27575555 DOI: 10.1016/j.kint.2016.06.033] [Cited by in Crossref: 53] [Cited by in F6Publishing: 46] [Article Influence: 8.8] [Reference Citation Analysis]
133 March DS, Graham-Brown MP, Stover CM, Bishop NC, Burton JO. Intestinal Barrier Disturbances in Haemodialysis Patients: Mechanisms, Consequences, and Therapeutic Options. Biomed Res Int 2017;2017:5765417. [PMID: 28194419 DOI: 10.1155/2017/5765417] [Cited by in F6Publishing: 15] [Reference Citation Analysis]
134 Jazani NH, Savoj J, Lustgarten M, Lau WL, Vaziri ND. Impact of Gut Dysbiosis on Neurohormonal Pathways in Chronic Kidney Disease. Diseases 2019;7:E21. [PMID: 30781823 DOI: 10.3390/diseases7010021] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 7.3] [Reference Citation Analysis]
135 Chen X, Gao S, Ruan M, Chen S, Xu J, Xing X, Pan X, Mei C, Mao Z. Shen-Shuai-Ning granule decreased serum concentrations of indoxyl sulphate in uremic patients undergoing peritoneal dialysis. Biosci Rep 2018;38:BSR20171694. [PMID: 29921575 DOI: 10.1042/BSR20171694] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
136 Sumida K, Molnar MZ, Potukuchi PK, Thomas F, Lu JL, Matsushita K, Yamagata K, Kalantar-Zadeh K, Kovesdy CP. Constipation and Incident CKD. J Am Soc Nephrol 2017;28:1248-58. [PMID: 28122944 DOI: 10.1681/ASN.2016060656] [Cited by in Crossref: 44] [Cited by in F6Publishing: 23] [Article Influence: 7.3] [Reference Citation Analysis]
137 Li A, Lee HY, Lin YC. The Effect of Ketoanalogues on Chronic Kidney Disease Deterioration: A Meta-Analysis. Nutrients 2019;11:E957. [PMID: 31035482 DOI: 10.3390/nu11050957] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 5.3] [Reference Citation Analysis]
138 Toth-Manikowski SM, Sirich TL, Meyer TW, Hostetter TH, Hwang S, Plummer NS, Hai X, Coresh J, Powe NR, Shafi T. Contribution of 'clinically negligible' residual kidney function to clearance of uremic solutes. Nephrol Dial Transplant 2020;35:846-53. [PMID: 30879076 DOI: 10.1093/ndt/gfz042] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
139 Ji C, Deng Y, Yang A, Lu Z, Chen Y, Liu X, Han L, Zou C. Rhubarb Enema Improved Colon Mucosal Barrier Injury in 5/6 Nephrectomy Rats May Associate With Gut Microbiota Modification. Front Pharmacol 2020;11:1092. [PMID: 32848732 DOI: 10.3389/fphar.2020.01092] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
140 Randall DW, Kieswich J, Swann J, McCafferty K, Thiemermann C, Curtis M, Hoyles L, Yaqoob MM. Batch effect exerts a bigger influence on the rat urinary metabolome and gut microbiota than uraemia: a cautionary tale. Microbiome 2019;7:127. [PMID: 31477171 DOI: 10.1186/s40168-019-0738-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
141 Chou CA, Lin CN, Chiu DT, Chen IW, Chen ST. Tryptophan as a surrogate prognostic marker for diabetic nephropathy. J Diabetes Investig 2018;9:366-74. [PMID: 28646618 DOI: 10.1111/jdi.12707] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
142 Li YJ, Chen X, Kwan TK, Loh YW, Singer J, Liu Y, Ma J, Tan J, Macia L, Mackay CR, Chadban SJ, Wu H. Dietary Fiber Protects against Diabetic Nephropathy through Short-Chain Fatty Acid-Mediated Activation of G Protein-Coupled Receptors GPR43 and GPR109A. J Am Soc Nephrol 2020;31:1267-81. [PMID: 32358041 DOI: 10.1681/ASN.2019101029] [Cited by in Crossref: 23] [Cited by in F6Publishing: 11] [Article Influence: 11.5] [Reference Citation Analysis]
143 Kimber C, Zhang S, Johnson C, West RE 3rd, Prokopienko AJ, Mahnken JD, Yu AS, Hoofnagle AN, Ir D, Robertson CE, Miyazaki M, Chonchol M, Jovanovich A, Kestenbaum B, Frank DN, Nolin TD, Stubbs JR. Randomized, Placebo-Controlled Trial of Rifaximin Therapy for Lowering Gut-Derived Cardiovascular Toxins and Inflammation in CKD. Kidney360 2020;1:1206-16. [PMID: 34322673 DOI: 10.34067/kid.0003942020] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
144 Cambier A, Gleeson PJ, Flament H, Le Stang MB, Monteiro RC. New therapeutic perspectives for IgA nephropathy in children. Pediatr Nephrol 2021;36:497-506. [PMID: 32040630 DOI: 10.1007/s00467-020-04475-w] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
145 Nallu A, Sharma S, Ramezani A, Muralidharan J, Raj D. Gut microbiome in chronic kidney disease: challenges and opportunities. Transl Res. 2017;179:24-37. [PMID: 27187743 DOI: 10.1016/j.trsl.2016.04.007] [Cited by in Crossref: 94] [Cited by in F6Publishing: 90] [Article Influence: 15.7] [Reference Citation Analysis]
146 Flores-Guerrero JL, Osté MCJ, Baraldi PB, Connelly MA, Garcia E, Navis G, Bakker SJL, Dullaart RPF. Association of Circulating Trimethylamine N-Oxide and Its Dietary Determinants with the Risk of Kidney Graft Failure: Results of the TransplantLines Cohort Study. Nutrients 2021;13:262. [PMID: 33477634 DOI: 10.3390/nu13010262] [Reference Citation Analysis]
147 Potrykus M, Czaja-Stolc S, Stankiewicz M, Kaska Ł, Małgorzewicz S. Intestinal Microbiota as a Contributor to Chronic Inflammation and Its Potential Modifications. Nutrients 2021;13:3839. [PMID: 34836095 DOI: 10.3390/nu13113839] [Reference Citation Analysis]
148 Cheng Y, Li Y, Benkowitz P, Lamina C, Köttgen A, Sekula P. The relationship between blood metabolites of the tryptophan pathway and kidney function: a bidirectional Mendelian randomization analysis. Sci Rep 2020;10:12675. [PMID: 32728058 DOI: 10.1038/s41598-020-69559-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
149 Patel C, Patel P, Acharya S. Therapeutic Prospective of a Spore-Forming Probiotic-Bacillus clausii UBBC07 Against Acetaminophen-Induced Uremia in Rats. Probiotics Antimicrob Proteins 2020;12:253-8. [PMID: 30879230 DOI: 10.1007/s12602-019-09540-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
150 Chan KW, Chow TY, Yu KY, Xu Y, Zhang NL, Wong VT, Li S, Tang SCW. SYmptom-Based STratification of DiabEtes Mellitus by Renal Function Decline (SYSTEM): A Retrospective Cohort Study and Modeling Assessment. Front Med (Lausanne) 2021;8:682090. [PMID: 34195211 DOI: 10.3389/fmed.2021.682090] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
151 Stanford J, Charlton K, Stefoska-Needham A, Ibrahim R, Lambert K. The gut microbiota profile of adults with kidney disease and kidney stones: a systematic review of the literature. BMC Nephrol 2020;21:215. [PMID: 32503496 DOI: 10.1186/s12882-020-01805-w] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
152 Toor MR, Singla A, Kim JK, Sumin X, DeVita MV, Michelis MF. Preventing the progression of chronic kidney disease: two case reports and review of the literature. Int Urol Nephrol 2014;46:2167-74. [PMID: 24948202 DOI: 10.1007/s11255-014-0762-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
153 Karaduta O, Glazko G, Dvanajscak Z, Arthur J, Mackintosh S, Orr L, Rahmatallah Y, Yeruva L, Tackett A, Zybailov B. Resistant starch slows the progression of CKD in the 5/6 nephrectomy mouse model. Physiol Rep 2020;8:e14610. [PMID: 33038060 DOI: 10.14814/phy2.14610] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
154 Hsu CN, Yang HW, Hou CY, Chang-Chien GP, Lin S, Tain YL. Melatonin Prevents Chronic Kidney Disease-Induced Hypertension in Young Rat Treated with Adenine: Implications of Gut Microbiota-Derived Metabolites. Antioxidants (Basel) 2021;10:1211. [PMID: 34439458 DOI: 10.3390/antiox10081211] [Reference Citation Analysis]
155 Gisewhite S, Stewart IJ, Beilman G, Lusczek E. Urinary metabolites predict mortality or need for renal replacement therapy after combat injury. Crit Care 2021;25:119. [PMID: 33757577 DOI: 10.1186/s13054-021-03544-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
156 Schugar RC, Willard B, Wang Z, Brown JM. Postprandial gut microbiota-driven choline metabolism links dietary cues to adipose tissue dysfunction. Adipocyte 2018;7:49-56. [PMID: 29172946 DOI: 10.1080/21623945.2017.1398295] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
157 Richards JL, Yap YA, McLeod KH, Mackay CR, Mariño E. Dietary metabolites and the gut microbiota: an alternative approach to control inflammatory and autoimmune diseases. Clin Transl Immunology 2016;5:e82. [PMID: 27350881 DOI: 10.1038/cti.2016.29] [Cited by in Crossref: 104] [Cited by in F6Publishing: 99] [Article Influence: 17.3] [Reference Citation Analysis]
158 Kitai T, Tang WHW. Gut microbiota in cardiovascular disease and heart failure. Clin Sci (Lond). 2018;132:85-91. [PMID: 29326279 DOI: 10.1042/cs20171090] [Cited by in Crossref: 34] [Cited by in F6Publishing: 17] [Article Influence: 8.5] [Reference Citation Analysis]
159 Nath KA. Dialysis Vascular Access Intervention and the Search for Biomarkers. J Am Soc Nephrol 2016;27:970-2. [PMID: 26453612 DOI: 10.1681/ASN.2015090982] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
160 Farrer AG, Wright SL, Skelly E, Eisenhofer R, Dobney K, Weyrich LS. Effectiveness of decontamination protocols when analyzing ancient DNA preserved in dental calculus. Sci Rep 2021;11:7456. [PMID: 33811235 DOI: 10.1038/s41598-021-86100-w] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
161 Irie J, Kanno Y, Kikuchi R, Yoshida T, Murai S, Watanabe M, Itoh H, Hayashi M. L-Carnitine improves gastrointestinal disorders and altered the intestinal microbiota in hemodialysis patients. Biosci Microbiota Food Health 2017;36:11-6. [PMID: 28243546 DOI: 10.12938/bmfh.16-009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
162 Meijers B, Farré R, Dejongh S, Vicario M, Evenepoel P. Intestinal Barrier Function in Chronic Kidney Disease. Toxins (Basel) 2018;10:E298. [PMID: 30029474 DOI: 10.3390/toxins10070298] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 7.3] [Reference Citation Analysis]
163 Gryp T, Glorieux G, Joossens M, Vaneechoutte M. Comparison of five assays for DNA extraction from bacterial cells in human faecal samples. J Appl Microbiol 2020;129:378-88. [PMID: 32034968 DOI: 10.1111/jam.14608] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
164 Sabanis N, Paschou E, Gavriilaki E, Mourounoglou M, Vasileiou S. Unexpected Abscess Localization of the Anterior Abdominal Wall in an ADPKD Patient Undergoing Hemodialysis. Case Rep Nephrol 2015;2015:982575. [PMID: 26301109 DOI: 10.1155/2015/982575] [Reference Citation Analysis]
165 Buchanan S, Combet E, Stenvinkel P, Shiels PG. Klotho, Aging, and the Failing Kidney. Front Endocrinol (Lausanne) 2020;11:560. [PMID: 32982966 DOI: 10.3389/fendo.2020.00560] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 8.0] [Reference Citation Analysis]
166 Gandolfini I, Regolisti G, Bazzocchi A, Maggiore U, Palmisano A, Piotti G, Fiaccadori E, Sabatino A. Frailty and Sarcopenia in Older Patients Receiving Kidney Transplantation. Front Nutr 2019;6:169. [PMID: 31781571 DOI: 10.3389/fnut.2019.00169] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
167 Rhee EP, Waikar SS, Rebholz CM, Zheng Z, Perichon R, Clish CB, Evans AM, Avila J, Denburg MR, Anderson AH, Vasan RS, Feldman HI, Kimmel PL, Coresh J; CKD Biomarkers Consortium. Variability of Two Metabolomic Platforms in CKD. Clin J Am Soc Nephrol 2019;14:40-8. [PMID: 30573658 DOI: 10.2215/CJN.07070618] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
168 Lau WL, Kalantar-Zadeh K, Vaziri ND. The Gut as a Source of Inflammation in Chronic Kidney Disease. Nephron. 2015;130:92-98. [PMID: 25967288 DOI: 10.1159/000381990] [Cited by in Crossref: 128] [Cited by in F6Publishing: 113] [Article Influence: 18.3] [Reference Citation Analysis]
169 Pedraza-Chaverri J, Sánchez-Lozada LG, Osorio-Alonso H, Tapia E, Scholze A. New Pathogenic Concepts and Therapeutic Approaches to Oxidative Stress in Chronic Kidney Disease. Oxid Med Cell Longev 2016;2016:6043601. [PMID: 27429711 DOI: 10.1155/2016/6043601] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 4.8] [Reference Citation Analysis]
170 Mafune A, Iwamoto T, Tsutsumi Y, Nakashima A, Yamamoto I, Yokoyama K, Yokoo T, Urashima M. Associations among serum trimethylamine-N-oxide (TMAO) levels, kidney function and infarcted coronary artery number in patients undergoing cardiovascular surgery: a cross-sectional study. Clin Exp Nephrol 2016;20:731-9. [PMID: 26676906 DOI: 10.1007/s10157-015-1207-y] [Cited by in Crossref: 48] [Cited by in F6Publishing: 51] [Article Influence: 6.9] [Reference Citation Analysis]
171 Ghosh SS, Gehr TW, Ghosh S. Curcumin and chronic kidney disease (CKD): major mode of action through stimulating endogenous intestinal alkaline phosphatase. Molecules. 2014;19:20139-20156. [PMID: 25474287 DOI: 10.3390/molecules191220139] [Cited by in Crossref: 50] [Cited by in F6Publishing: 41] [Article Influence: 6.3] [Reference Citation Analysis]
172 Kim SM, Song IH. The clinical impact of gut microbiota in chronic kidney disease. Korean J Intern Med 2020;35:1305-16. [PMID: 32872729 DOI: 10.3904/kjim.2020.411] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
173 Al Khodor S, Shatat IF. Gut microbiome and kidney disease: a bidirectional relationship. Pediatr Nephrol 2017;32:921-31. [PMID: 27129691 DOI: 10.1007/s00467-016-3392-7] [Cited by in Crossref: 58] [Cited by in F6Publishing: 53] [Article Influence: 9.7] [Reference Citation Analysis]
174 Lu CY, Chen YC, Lu YW, Muo CH, Chang RE. Association of Constipation with risk of end-stage renal disease in patients with chronic kidney disease. BMC Nephrol 2019;20:304. [PMID: 31382927 DOI: 10.1186/s12882-019-1481-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
175 Zayed M, Iohara K. Effects of p-Cresol on Senescence, Survival, Inflammation, and Odontoblast Differentiation in Canine Dental Pulp Stem Cells. Int J Mol Sci 2020;21:E6931. [PMID: 32967298 DOI: 10.3390/ijms21186931] [Reference Citation Analysis]
176 Wu S, Wang M, Zhang M, He JQ. Metabolomics and microbiomes for discovering biomarkers of antituberculosis drugs-induced hepatotoxicity. Arch Biochem Biophys 2022;:109118. [PMID: 34999018 DOI: 10.1016/j.abb.2022.109118] [Reference Citation Analysis]
177 Elias E, Targownik LE. The Clinician's Guide to Proton Pump Inhibitor Related Adverse Events. Drugs 2019;79:715-31. [PMID: 30972661 DOI: 10.1007/s40265-019-01110-3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 4.3] [Reference Citation Analysis]
178 Vanholder R, Glorieux G. The intestine and the kidneys: a bad marriage can be hazardous. Clin Kidney J 2015;8:168-79. [PMID: 25815173 DOI: 10.1093/ckj/sfv004] [Cited by in Crossref: 54] [Cited by in F6Publishing: 50] [Article Influence: 7.7] [Reference Citation Analysis]
179 Guldris SC, Parra EG, Amenós AC. Gut microbiota in chronic kidney disease. Nefrología (English Edition) 2017;37:9-19. [DOI: 10.1016/j.nefroe.2017.01.017] [Cited by in Crossref: 14] [Cited by in F6Publishing: 3] [Article Influence: 2.8] [Reference Citation Analysis]
180 Amornphimoltham P, Yuen PST, Star RA, Leelahavanichkul A. Gut Leakage of Fungal-Derived Inflammatory Mediators: Part of a Gut-Liver-Kidney Axis in Bacterial Sepsis. Dig Dis Sci 2019;64:2416-28. [PMID: 30863955 DOI: 10.1007/s10620-019-05581-y] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 7.3] [Reference Citation Analysis]
181 Weber GJ, Pushpakumar S, Tyagi SC, Sen U. Homocysteine and hydrogen sulfide in epigenetic, metabolic and microbiota related renovascular hypertension. Pharmacol Res 2016;113:300-12. [PMID: 27602985 DOI: 10.1016/j.phrs.2016.09.002] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 5.8] [Reference Citation Analysis]
182 Camerotto C, Cupisti A, D'Alessandro C, Muzio F, Gallieni M. Dietary Fiber and Gut Microbiota in Renal Diets. Nutrients 2019;11:E2149. [PMID: 31505733 DOI: 10.3390/nu11092149] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
183 Jawale CV, Li DD, Ramani K, Lin L, Li K, Methe B, Biswas PS. Uremia Coupled with Mucosal Damage Predisposes Mice with Kidney Disease to Systemic Infection by Commensal Candida albicans. Immunohorizons 2021;5:16-24. [PMID: 33451988 DOI: 10.4049/immunohorizons.2000114] [Reference Citation Analysis]
184 Sharaf El Din UAA, Salem MM, Abdulazim DO. Stop chronic kidney disease progression: Time is approaching. World J Nephrol 2016; 5(3): 258-273 [PMID: 27152262 DOI: 10.5527/wjn.v5.i3.258] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
185 Roviello G, Iannone LF, Bersanelli M, Mini E, Catalano M. The gut microbiome and efficacy of cancer immunotherapy. Pharmacol Ther 2021;:107973. [PMID: 34453999 DOI: 10.1016/j.pharmthera.2021.107973] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
186 Flothow DJG, Suwelack B, Pavenstädt H, Schütte-Nütgen K, Reuter S. The Effect of Proton Pump Inhibitor Use on Renal Function in Kidney Transplanted Patients. J Clin Med 2020;9:E258. [PMID: 31963650 DOI: 10.3390/jcm9010258] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
187 Salvadori M, Tsalouchos A. Microbiota, renal disease and renal transplantation. World J Transplant 2021; 11(3): 16-36 [PMID: 33816144 DOI: 10.5500/wjt.v11.i3.16] [Reference Citation Analysis]
188 Shivani S, Chattopadhyay A, Chuang EY. Targeting the gut microbiome for non-communicable diseases: present and future. Ann Transl Med 2021;9:361. [PMID: 33842582 DOI: 10.21037/atm-21-144] [Reference Citation Analysis]
189 Bai Q, Guo HX, Su CY, Han QF, Wang T, Tang W. Serum Sphingosine-1-phosphate level and peritonitis in peritoneal dialysis patients. Ren Fail 2020;42:829-35. [PMID: 32787649 DOI: 10.1080/0886022X.2020.1805763] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
190 Liu F, Xu X, Chao L, Chen K, Shao A, Sun D, Hong Y, Hu R, Jiang P, Zhang N, Xiao Y, Yan F, Feng N. Alteration of the Gut Microbiome in Chronic Kidney Disease Patients and Its Association With Serum Free Immunoglobulin Light Chains. Front Immunol 2021;12:609700. [PMID: 33868230 DOI: 10.3389/fimmu.2021.609700] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
191 Neff CP, Krueger O, Xiong K, Arif S, Nusbacher N, Schneider JM, Cunningham AW, Armstrong A, Li S, McCarter MD, Campbell TB, Lozupone CA, Palmer BE. Fecal Microbiota Composition Drives Immune Activation in HIV-infected Individuals. EBioMedicine 2018;30:192-202. [PMID: 29650491 DOI: 10.1016/j.ebiom.2018.03.024] [Cited by in Crossref: 42] [Cited by in F6Publishing: 41] [Article Influence: 10.5] [Reference Citation Analysis]
192 Zughaier SM, Alvarez JA, Sloan JH, Konrad RJ, Tangpricha V. The role of vitamin D in regulating the iron-hepcidin-ferroportin axis in monocytes. J Clin Transl Endocrinol 2014;1:19-25. [PMID: 25097830 DOI: 10.1016/j.jcte.2014.01.003] [Cited by in Crossref: 59] [Cited by in F6Publishing: 54] [Article Influence: 7.4] [Reference Citation Analysis]
193 Mihai S, Codrici E, Popescu ID, Enciu AM, Albulescu L, Necula LG, Mambet C, Anton G, Tanase C. Inflammation-Related Mechanisms in Chronic Kidney Disease Prediction, Progression, and Outcome. J Immunol Res 2018;2018:2180373. [PMID: 30271792 DOI: 10.1155/2018/2180373] [Cited by in Crossref: 106] [Cited by in F6Publishing: 98] [Article Influence: 26.5] [Reference Citation Analysis]
194 Lu Z, Ji C, Luo X, Lan Y, Han L, Chen Y, Liu X, Lin Q, Lu F, Wu X, Guo R, Zou C. Nanoparticle-Mediated Delivery of Emodin via Colonic Irrigation Attenuates Renal Injury in 5/6 Nephrectomized Rats. Front Pharmacol 2020;11:606227. [PMID: 33551808 DOI: 10.3389/fphar.2020.606227] [Reference Citation Analysis]
195 Simeoni M, Citraro ML, Cerantonio A, Deodato F, Provenzano M, Cianfrone P, Capria M, Corrado S, Libri E, Comi A, Pujia A, Abenavoli L, Andreucci M, Cocchi M, Montalcini T, Fuiano G. An open-label, randomized, placebo-controlled study on the effectiveness of a novel probiotics administration protocol (ProbiotiCKD) in patients with mild renal insufficiency (stage 3a of CKD). Eur J Nutr 2019;58:2145-56. [PMID: 30076458 DOI: 10.1007/s00394-018-1785-z] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
196 Vasylyeva TL, Singh R. Gut Microbiome and Kidney Disease in Pediatrics: Does Connection Exist? Front Microbiol 2016;7:235. [PMID: 26973613 DOI: 10.3389/fmicb.2016.00235] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
197 Mo Y, Lu Z, Wang L, Ji C, Zou C, Liu X. The Aryl Hydrocarbon Receptor in Chronic Kidney Disease: Friend or Foe? Front Cell Dev Biol 2020;8:589752. [PMID: 33415104 DOI: 10.3389/fcell.2020.589752] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
198 Hassan MS, Ahmed YS, Sarhaan EI, Mehanna NS, Madbouli NN, Abdelgawad MA. Effect of dietary synbiotic supplementation on serum indoxyl sulfate in prevalent hemodialysis patients. Egypt J Intern Med 2022;34. [DOI: 10.1186/s43162-021-00096-3] [Reference Citation Analysis]
199 Molanaei H, Qureshi AR, Heimbürger O, Lindholm B, Diczfalusy U, Anderstam B, Bertilsson L, Stenvinkel P. Inflammation down-regulates CYP3A4-catalysed drug metabolism in hemodialysis patients. BMC Pharmacol Toxicol 2018;19:33. [PMID: 29941014 DOI: 10.1186/s40360-018-0221-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
200 Hassan MO, Duarte R, Dix-Peek T, Dickens C, Naidoo S, Vachiat A, Grinter S, Manga P, Naicker S. Transforming Growth Factor-β Protects against Inflammation-Related Atherosclerosis in South African CKD Patients. Int J Nephrol 2018;2018:8702372. [PMID: 29977619 DOI: 10.1155/2018/8702372] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
201 Paul AK, Paul A, Jahan R, Jannat K, Bondhon TA, Hasan A, Nissapatorn V, Pereira ML, Wilairatana P, Rahmatullah M. Probiotics and Amelioration of Rheumatoid Arthritis: Significant Roles of Lactobacillus casei and Lactobacillus acidophilus. Microorganisms 2021;9:1070. [PMID: 34065638 DOI: 10.3390/microorganisms9051070] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
202 Zununi Vahed S, Mostafavi S, Hosseiniyan Khatibi SM, Shoja MM, Ardalan M. Vascular Calcification: An Important Understanding in Nephrology. Vasc Health Risk Manag 2020;16:167-80. [PMID: 32494148 DOI: 10.2147/VHRM.S242685] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
203 Oosterwijk MM, Soedamah-Muthu SS, Geleijnse JM, Bakker SJL, Navis G, Binnenmars SH, Gant CM, Laverman GD. High Dietary Intake of Vegetable Protein Is Associated With Lower Prevalence of Renal Function Impairment: Results of the Dutch DIALECT-1 Cohort. Kidney Int Rep 2019;4:710-9. [PMID: 31080926 DOI: 10.1016/j.ekir.2019.02.009] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 4.3] [Reference Citation Analysis]
204 Bin-Jumah MN, Gilani SJ, Hosawi S, Al-Abbasi FA, Zeyadi M, Imam SS, Alshehri S, Ghoneim MM, Nadeem MS, Kazmi I. Pathobiological Relationship of Excessive Dietary Intake of Choline/L-Carnitine: A TMAO Precursor-Associated Aggravation in Heart Failure in Sarcopenic Patients. Nutrients 2021;13:3453. [PMID: 34684454 DOI: 10.3390/nu13103453] [Reference Citation Analysis]
205 Li L, Ma L, Fu P. Gut microbiota-derived short-chain fatty acids and kidney diseases. Drug Des Devel Ther 2017;11:3531-42. [PMID: 29270002 DOI: 10.2147/DDDT.S150825] [Cited by in Crossref: 46] [Cited by in F6Publishing: 23] [Article Influence: 9.2] [Reference Citation Analysis]
206 Rydzewska-Rosołowska A, Sroka N, Kakareko K, Rosołowski M, Zbroch E, Hryszko T. The Links between Microbiome and Uremic Toxins in Acute Kidney Injury: Beyond Gut Feeling-A Systematic Review. Toxins (Basel) 2020;12:E788. [PMID: 33322362 DOI: 10.3390/toxins12120788] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
207 Takeshita M, Tanaka A, Nakamura T, Sato E, Node K. Effect of Lubiprostone on Urinary Protein Excretion: A Report of Two IgA Nephropathy Patients with Chronic Constipation. Intern Med 2019;58:3255-9. [PMID: 31292404 DOI: 10.2169/internalmedicine.3158-19] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
208 Viana SD, Nunes S, Reis F. ACE2 imbalance as a key player for the poor outcomes in COVID-19 patients with age-related comorbidities - Role of gut microbiota dysbiosis. Ageing Res Rev. 2020;62:101123. [PMID: 32683039 DOI: 10.1016/j.arr.2020.101123] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 18.5] [Reference Citation Analysis]
209 Matsuo K, Yamamoto S, Wakamatsu T, Takahashi Y, Kawamura K, Kaneko Y, Goto S, Kazama JJ, Narita I. Increased Proinflammatory Cytokine Production and Decreased Cholesterol Efflux Due to Downregulation of ABCG1 in Macrophages Exposed to Indoxyl Sulfate. Toxins (Basel) 2015;7:3155-66. [PMID: 26287243 DOI: 10.3390/toxins7083155] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
210 Ho A, Sinick J, Esko T, Fischer K, Menni C, Zierer J, Matey-Hernandez M, Fortney K, Morgen EK. Circulating glucuronic acid predicts healthspan and longevity in humans and mice. Aging (Albany NY) 2019;11:7694-706. [PMID: 31557729 DOI: 10.18632/aging.102281] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
211 Kumar D, Mukherjee SS, Chakraborty R, Roy RR, Pandey A, Patra S, Dey S. The emerging role of gut microbiota in cardiovascular diseases. Indian Heart J 2021;73:264-72. [PMID: 34154741 DOI: 10.1016/j.ihj.2021.04.008] [Reference Citation Analysis]
212 Mishima E, Fukuda S, Shima H, Hirayama A, Akiyama Y, Takeuchi Y, Fukuda NN, Suzuki T, Suzuki C, Yuri A. Alteration of the Intestinal Environment by Lubiprostone Is Associated with Amelioration of Adenine-Induced CKD. J Am Soc Nephrol. 2015;26:1787-1794. [PMID: 25525179 DOI: 10.1681/asn.2014060530] [Cited by in Crossref: 110] [Cited by in F6Publishing: 57] [Article Influence: 13.8] [Reference Citation Analysis]
213 McPherson KC, Shields CA, Poudel B, Fizer B, Pennington A, Szabo-Johnson A, Thompson WL, Cornelius DC, Williams JM. Impact of obesity as an independent risk factor for the development of renal injury: implications from rat models of obesity. Am J Physiol Renal Physiol 2019;316:F316-27. [PMID: 30539649 DOI: 10.1152/ajprenal.00162.2018] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
214 Panpetch W, Kullapanich C, Dang CP, Visitchanakun P, Saisorn W, Wongphoom J, Wannigama DL, Thim-Uam A, Patarakul K, Somboonna N, Tumwasorn S, Leelahavanichkul A. Candida Administration Worsens Uremia-Induced Gut Leakage in Bilateral Nephrectomy Mice, an Impact of Gut Fungi and Organismal Molecules in Uremia. mSystems 2021;6:e01187-20. [PMID: 33436518 DOI: 10.1128/mSystems.01187-20] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
215 Suryavanshi MV, Bhute SS, Jadhav SD, Bhatia MS, Gune RP, Shouche YS. Hyperoxaluria leads to dysbiosis and drives selective enrichment of oxalate metabolizing bacterial species in recurrent kidney stone endures. Sci Rep 2016;6:34712. [PMID: 27708409 DOI: 10.1038/srep34712] [Cited by in Crossref: 43] [Cited by in F6Publishing: 36] [Article Influence: 7.2] [Reference Citation Analysis]
216 Darshi M, Van Espen B, Sharma K. Metabolomics in Diabetic Kidney Disease: Unraveling the Biochemistry of a Silent Killer. Am J Nephrol 2016;44:92-103. [PMID: 27410520 DOI: 10.1159/000447954] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 6.3] [Reference Citation Analysis]
217 Frazier R, Cai X, Lee J, Bundy JD, Jovanovich A, Chen J, Deo R, Lash JP, Anderson AH, Go AS, Feldman HI, Shafi T, Rhee EP, Miyazaki M, Chonchol M, Isakova T. Deoxycholic Acid and Risks of Cardiovascular Events, ESKD, and Mortality in CKD: The CRIC Study. Kidney Medicine 2022;4:100387. [DOI: 10.1016/j.xkme.2021.09.004] [Reference Citation Analysis]
218 Lowenstein J, Nigam SK. Uremic Toxins in Organ Crosstalk. Front Med (Lausanne) 2021;8:592602. [PMID: 33937275 DOI: 10.3389/fmed.2021.592602] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
219 Zhang Q, Zhang Y, Zeng L, Chen G, Zhang, Liu M, Sheng H, Hu X, Su J, Zhang D, Lu F, Liu X, Zhang L. The Role of Gut Microbiota and Microbiota-Related Serum Metabolites in the Progression of Diabetic Kidney Disease. Front Pharmacol 2021;12:757508. [PMID: 34899312 DOI: 10.3389/fphar.2021.757508] [Reference Citation Analysis]